Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes

Cardiovascular Research

Volumn 43, Issue 4, 1999, Pages 1049-1059

  Lau, Herbert K F ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Biochemistry; Experimental; Regulatory systems

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; PROTEINASE; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; EPITHELIOID CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CAROTID ARTERIES; CELL SEPARATION; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME TESTS; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET-DERIVED GROWTH FACTOR; PROTEASE INHIBITORS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032846085     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00136-4     Document Type: Article

References (34)

1. Wohrley J., Frid M., Moiseeva E., et al. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest. 96:1996;273-281.
2. Orlandi A., Ehrlich H.P., Ropraz P., Spagnoli L.G., Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscl Thromb. 14:1994;982-989.
3. Frid M.G., Moiseeva E.P., Stenmark K.R. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res. 75:1994;669-681.
4. Majesky M.W., Giachelli C.M., Reidy M.A., Schwartz S.M. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 71:1992;759-768.
5. Bochaton-Piallat M.-L., Gabbiani F., Ropraz P., Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arteriosclerosis & Thrombosis. 13:1993;1449-1455.
6. Glukhova M.A., Frid M.G., Koteliansky V.E. Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J Biol Chem. 265:1990;13042-13046.
7. Aikawa M., Sivam P., Kuro-o M., et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res. 73:1993;1000-1012.
8. Bochaton-Piallat M.-L., Ropraz P., Gabbiani F., Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening 3. Artherioscler Thromb Vasc Biol. 16:1996;815-820.
9. Seifert R.A., Schwartz S.M., Bowen-Pope D.F. Developmentally regulated production of platelet-derived growth factor-like molecules. Nature. 311:1984;669-671.
10. Walker L.N., Bowen-Pope D.F., Ross R., Reidy M.A. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accopmanies proliferation after arterial injury. Proc Natl Acad Sci USA. 83:1986;7311-7315.
11. Lemire J.M., Covin C.W., White S., Giachelli C.M., Schwartz S.M. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol. 144:1994;1068-1081.
12. Liotta L.A., Rao C.N., Barsky S.H. Tumor invasion and the extracellular matrix. Lab Invest. 49:1983;636-648.
13. Paranjpe M., Engel L., Young N., Liotta L.A. Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci. 26:1980;1223-1231.
14. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodelling. Trend Genet. 6:1990;121-125.
15. Doeherty A.J.P., Murphy G. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis. 49:1990;469-479.
16. Clowes A.W., Clowes M.M., Au Y.P.T., Reidy M.A., Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue plasminogen activator during migration in injured rat carotid artery. Circ Res. 67:1990;61-67.
17. Jackson C.I., Reidy M.A. The role of plasminogen activation in smooth muscle cell migration after arterial injury. Ann New York Acad Sci. 667:1992;141-150.
18. Carmeliet P., Moons L., Herbert J.-M. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res. 81:1997;829-839.
19. Zempo N., Kenagy R.D., Au Y.P.T., et al. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg. 20:1994;209-217.
20. Bendeck M.P., Zempo N., Clowes A.W., Galardy R.E., Reidy M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 75:1994;539-545.
21. Hasenstab D., Forough R., Clowes A.W. Plasminogen activator inhibitor type l and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats. Circ Res. 80:1997;490-496.
22. Ross R. The smooth muscle cell: II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 50:1971;172-186.
23. Gimbrone M.A., Cotran R.S. Human vascular smooth muscle in culture. Lab Invest. 33:1975;16-27.
24. Heussen C., Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 102:1980;196-202.
25. Laemmlie U.K. Cleavage of structural proteins during assembly of head bacteriophage T4. Nature. 227:1970;680-682.
26. Majack R.A., Cook S.C., Bornstein P. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol. 101:1985;1059-1070.
27. Angles-Cano E., Boutiere B., Arenoux D., et al. Release pattern of vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay. Thromb Haemost. 58:1987;843-849.
28. Kung S.K.P., Lau H.K.F. Characterization of immunotrap assays for urokinase plasminogen activator and its inhibitors and measurements of these molecules in human plasma and mouse macrophage in culture. Int J Biochem. 25:1995;781-788.
29. McCaffrey T.A., Nicholson A.C., Szabo P.E., Weksler M.E., Weksler B.B. Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J Exp Med. 167:1988;163-174.
30. Hultgardh-Nilsson A., Krondahl U., Querol-Ferrer V., Ringertz N.R. Differences in growth factor response in smooth muscle cells isolated from adult and neonatal rat arteries. Differentiation. 47:1991;99-105.
31. Bochaton-Piallat M.-L., Gabbiani F., Ropraz P., Gabbiani G. Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features. Differentiation. 49:1992;175-185.
32. Cook C.L., Weiser M.C.M., Schwartz P.E., Jones C.L., Majack R.A. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res. 74:1994;189-196.
33. Lemire J.M., Potter-Perigo S., Hall K.L., Wight T.N., Schwartz S.M. Distinct rat aortic smooth muscle cells differ in versican/PG-M expression. Arterioscle Thromb Vasc Biol. 16:1996;821-829.
34. Bochaton-Piallat M.-L., Gabbiani G., Pepper M.S. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res. 82:1998;1086-1093.